GlobeNewswire: DNA Genotek Contains the last 10 of 2 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T15:01:36ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2020/05/04/2026578/0/en/DNA-Genotek-s-ORAcollect-RNA-kit-included-in-EUA-granted-to-Biocerna-SARS-CoV-2-test.html?f=22&fvtc=4&fvtv=58256DNA Genotek’s ORAcollect®·RNA kit included in EUA granted to Biocerna SARS-CoV-2 test2020-05-04T10:00:00Z<![CDATA[OTTAWA, May 04, 2020 (GLOBE NEWSWIRE) -- DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that its ORAcollect®·RNA kit (OR-100) was included as the collection device for anterior nares (nasal) samples under a U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) granted to Biocerna LLC for its PCR-based SARS-CoV-2 assay.]]>https://www.globenewswire.com/news-release/2020/01/22/1973499/0/en/DNA-Genotek-Announces-FDA-General-Use-Clearance-for-Oragene-Dx-Family-of-Products.html?f=22&fvtc=4&fvtv=58256DNA Genotek Announces FDA General Use Clearance for Oragene®·Dx Family of Products2020-01-22T11:00:00Z<![CDATA[OTTAWA, Jan. 22, 2020 (GLOBE NEWSWIRE) -- DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that the U.S. Food and Drug Administration (FDA) has granted a general use 510(k) clearance for its Oragene®•Dx family of products.]]>